CBLL
NASDAQCeriBell Inc.
$21.26+0.18 (+0.85%)
News25/Ratings8
News · 26 weeks78+67%
2025-10-262026-04-19
Mix3490d
- Insider21(62%)
- SEC Filings8(24%)
- Earnings3(9%)
- Other2(6%)
Latest news
25 items- PRCeribell to Report First Quarter 2026 Financial Results on May 11, 2026SUNNYVALE, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that it will release financial results for the first quarter of 2026 after the close of trading on Monday, May 11, 2026. Company management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET on May 11, 2026. Investors interested in listening to the conference call may do so by dialing (800) 715-9871 for domestic callers or (646) 307-1963 for international callers and providing access code 1880547. A li
- SECSEC Form DEFA14A filed by CeriBell Inc.DEFA14A - Ceribell, Inc. (0001861107) (Filer)
- SECSEC Form DEF 14A filed by CeriBell Inc.DEF 14A - Ceribell, Inc. (0001861107) (Filer)
- INSIDERSEC Form 4 filed by Chao Xingjuan4 - Ceribell, Inc. (0001861107) (Issuer)
- SECSEC Form 144 filed by CeriBell Inc.144 - Ceribell, Inc. (0001861107) (Subject)
- INSIDERSEC Form 4 filed by Chao Xingjuan4 - Ceribell, Inc. (0001861107) (Issuer)
- INSIDERSEC Form 4 filed by Blumberg Scott4 - Ceribell, Inc. (0001861107) (Issuer)
- INSIDERSEC Form 4 filed by Foehr David4 - Ceribell, Inc. (0001861107) (Issuer)
- INSIDERSEC Form 4 filed by Manni Joseph S.4 - Ceribell, Inc. (0001861107) (Issuer)
- INSIDERSEC Form 4 filed by Woo Raymond4 - Ceribell, Inc. (0001861107) (Issuer)
- INSIDERSEC Form 4 filed by Chao Xingjuan4 - Ceribell, Inc. (0001861107) (Issuer)
- INSIDERSenior VP, Finance and PAO Foehr David sold $81,168 worth of shares (4,560 units at $17.80) and exercised 4,560 shares at a strike of $4.70 (SEC Form 4)4 - Ceribell, Inc. (0001861107) (Issuer)
- INSIDERDirector Robertson Rebecca B sold $14,721 worth of shares (827 units at $17.80), decreasing direct ownership by 4% to 18,749 units (SEC Form 4)4 - Ceribell, Inc. (0001861107) (Issuer)
- INSIDERPresident and CEO Chao Xingjuan exercised 25,000 shares at a strike of $4.70 and sold $680,564 worth of shares (39,000 units at $17.45), decreasing direct ownership by 2% to 711,164 units (SEC Form 4)4 - Ceribell, Inc. (0001861107) (Issuer)
- INSIDERChief Technology Officer Woo Raymond exercised 11,112 shares at a strike of $4.37 and sold $147,602 worth of shares (8,087 units at $18.25) (SEC Form 4)4 - Ceribell, Inc. (0001861107) (Issuer)
- SECSEC Form 144 filed by CeriBell Inc.144 - Ceribell, Inc. (0001861107) (Subject)
- INSIDERSenior VP, Finance and PAO Foehr David sold $26,865 worth of shares (1,350 units at $19.90), decreasing direct ownership by 7% to 17,550 units (SEC Form 4)4 - Ceribell, Inc. (0001861107) (Issuer)
- INSIDERChief Revenue Officer Manni Joseph S. sold $15,199 worth of shares (768 units at $19.79), decreasing direct ownership by 3% to 26,933 units (SEC Form 4)4 - Ceribell, Inc. (0001861107) (Issuer)
- INSIDERChief Technology Officer Woo Raymond sold $13,952 worth of shares (705 units at $19.79), decreasing direct ownership by 0.42% to 166,912 units (SEC Form 4)4 - Ceribell, Inc. (0001861107) (Issuer)
- INSIDERChief Financial Officer Blumberg Scott sold $15,990 worth of shares (808 units at $19.79), decreasing direct ownership by 0.68% to 118,334 units (SEC Form 4)4 - Ceribell, Inc. (0001861107) (Issuer)
- INSIDERPresident and CEO Chao Xingjuan sold $41,242 worth of shares (2,084 units at $19.79), decreasing direct ownership by 0.29% to 725,164 units (SEC Form 4)4 - Ceribell, Inc. (0001861107) (Issuer)
- SECSEC Form S-8 filed by CeriBell Inc.S-8 - Ceribell, Inc. (0001861107) (Filer)
- SECSEC Form 10-K filed by CeriBell Inc.10-K - Ceribell, Inc. (0001861107) (Filer)
- SECCeriBell Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Ceribell, Inc. (0001861107) (Filer)
- PRCeribell Reports Fourth Quarter and Full Year 2025 Financial ResultsSUNNYVALE, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (NASDAQ:CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 & Recent Highlights Reported total revenue of $24.8 million in the fourth quarter of 2025, a 34% increase compared to the same period in 2024Delivered total revenue of $89.1 million for the full year of 2025, a 36% increase over the prior yearEnded the year with 647 total active accountsAchieved gross margin of 87% in the fourth quarter of 2025 and 8